Standout Papers
- Excluding Pulmonary Embolism at the Bedside without Diagnostic Imaging: Management of Patients with Suspected Pulmonary Embolism Presenting to the Emergency Department by Using a Simple Clinical Model and
d -dimer (2001) - Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis (2003)
- Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer (2000)
Citation Impact
Citing Papers
Minimum sample size for developing a multivariable prediction model: PART II ‐ binary and time‐to‐event outcomes
2018
Standardized Low–Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery
2009
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation
2007
Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation
2007
Clinical outcomes with unfractionated heparin or low‐molecular‐weight heparin as bridging therapy in patients on long‐term oral anticoagulants: the REGIMEN registry
2006
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
2020 Standout
Aspirin for Preventing the Recurrence of Venous Thromboembolism
2012
Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules
2011
Validation of a clinical prognostic model to identify low‐risk patients with pulmonary embolism
2007
Individually tailored duration of elastic compression therapy in relation to incidence of the postthrombotic syndrome
2010
The Effectiveness of Warfarin Dosing from a Nomogram Compared with House Staff Dosing
2007
The validation and reproducibility of the pulmonary embolism severity index
2010
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Benefits and risks of using clopidogrel before coronary artery bypass surgery: Systematic review and meta-analysis of randomized trials and observational studies
2011
Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: The blind, prospective CALTHRO study
2010
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes
2010
Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta‐analysis
2013
Is Incidentally Detected Pulmonary Embolism in Cancer Patients Less Severe? A Case-Control Study
2011
Periprocedural Anticoagulation Management of Patients With Nonvalvular Atrial Fibrillation
2008
Dosage of enoxaparin among obese and renal impairment patients
2004
Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial☆
2009
Symptomatic subsegmental pulmonary embolism: what is the next step?
2012
When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found
2013
Diagnosing pulmonary embolism in outpatients with clinical assessment, D-Dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study
2004
Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients
2009
Massive pulmonary embolism with anterolateral ST-segment elevation: electrocardiogram limitations and the role of echocardiogram
2008
Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study
2012
Ambulatory management of pulmonary embolism: a pragmatic evaluation
2010
Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis
2012
Evidence-Based Management of Anticoagulant Therapy
2012
Warfarin Maintenance Dosing Patterns in Clinical Practice
2005
Framework for the impact analysis and implementation of Clinical Prediction Rules (CPRs)
2011
Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-Up Study
2009
Elevated Heart-Type Fatty Acid-Binding Protein Levels on Admission Predict an Adverse Outcome in Normotensive Patients With Acute Pulmonary Embolism
2010
New oral antithrombotics: a need for laboratory monitoring. For
2010
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Apixaban for Extended Treatment of Venous Thromboembolism
2012
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low‐molecular‐weight heparin to avoid urgent ultrasonographic evaluation
2006
Perioperative Management of Antithrombotic Therapy
2012 Standout
Assessment of Cardiac Stress From Massive Pulmonary Embolism With 12-Lead ECG
2001
Oral Anticoagulant Therapy
2012 Standout
Optimized retrieval of primary care clinical prediction rules from MEDLINE to establish a web-based register
2011
Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor
2010
Antithrombotic Therapy for VTE Disease
2016 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Perioperative management of patients receiving vitamin K antagonists
2006
Intracranial and fatal bleeding according to indication for long‐term oral anticoagulant therapy
2010
Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?
2009
Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients
2004
The role of vena caval filters in the management of venous thromboembolism
2004
Risk of Thromboembolism With Short-term Interruption of Warfarin Therapy
2008
Multidetector Computed Tomography for Acute Pulmonary Embolism
2006 Standout
Prognostic Value of ECG Among Patients with Acute Pulmonary Embolism and Normal Blood Pressure
2009
Cardiovascular implications from untreated human immunodeficiency virus infection
2011
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
2013
Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism
2014
Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry)
2008
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype
2005
Mobilization versus immobilization in the treatment of acute proximal deep venous thrombosis: a prospective, randomized, open, multicentre trial
2006
Concerns in using multi-detector computed tomography for diagnosing pulmonary embolism in daily practice. A cross-sectional analysis using expert opinion as reference standard
2012
Risk of Deep Vein Thrombosis Following a Single Negative Whole-Leg Compression Ultrasound
2010
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Can Selected Patients With Newly Diagnosed Pulmonary Embolism Be Safely Treated Without Hospitalization? A Systematic Review
2012
Treatment of Deep-Vein Thrombosis
2004
A Clinical Prediction Rule for Identifying Short-Term Risk of Adverse Events in Patients With Pulmonary Thromboembolism
2007
A Prospective Natural-History Study of Coronary Atherosclerosis
2011 Standout
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention
2014
Self-monitoring of oral anticoagulation: a systematic review and meta-analysis
2006
Out of hospital treatment of acute pulmonary embolism in patients with a low NT‐proBNP level
2010
Air travel and thrombosis
2005
Diagnosis of DVT
2012
Serial 2-Point Ultrasonography Plus D-Dimer vs Whole-Leg Color-Coded Doppler Ultrasonography for Diagnosing Suspected Symptomatic Deep Vein Thrombosis
2008
Pulmonary embolism and deep vein thrombosis
2012
High D ‐dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes
2006
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Deep Venous Thrombosis
2004
Increased troponin I predicts in-hospital occurrence of hemodynamic instability in patients with sub-massive or non-massive pulmonary embolism independent to clinical, echocardiographic and laboratory information
2007
Platelet Activation and Atherothrombosis
2007 Standout
Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
2012
Validation, updating and impact of clinical prediction rules: A review
2008
Self-Managed Long-Term Low-Molecular-Weight Heparin Therapy: The Balance of Benefits and Harms
2007
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials
2011
Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy
2010 Standout
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
2006
Perioperative Management of Oral Anticoagulation: When and How to Bridge
2006
Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism
2006
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Medical management of patients with brain tumors
2006
Post-thrombotic syndrome, functional disability and quality of life after upper extremity deep venous thrombosis in adults
2005
Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency
2005
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Electrocardiography and Wells scoring in predicting the anatomic severity of pulmonary embolism
2007
Malignant Gliomas in Adults
2008 Standout
Prevention of Venous Thromboembolism
2004 Standout
Acute venous thromboembolism in patients with recent major bleeding. The influence of the site of bleeding and the time elapsed on outcome
2006
Randomized, Prospective Trial Comparing Bridging Therapy Using Low-Molecular-Weight Heparin With Maintenance of Oral Anticoagulation During Extraction of Teeth
2009
Major Pulmonary Embolism
2002
Pre-eclampsia
2021
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation
2011
The Perioperative Management of Antithrombotic Therapy
2008
Comparison of Safety of Subcutaneous Enoxaparin as Outpatient Anticoagulation Bridging Therapy in Patients With a Mechanical Heart Valve Versus Patients With Nonvalvular Atrial Fibrillation
2009
D‐dimer at venous thrombosis diagnosis is associated with risk of recurrence
2017
Thromboembolic Consequences of Subtherapeutic Anticoagulation in Patients Stabilized on Warfarin Therapy: The Low INR Study
2008
Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low–molecular weight heparin
2009
Value of Risk Stratification to Increase the Predictive Validity of HbA1c in Screening for Undiagnosed Diabetes in the US Population
2008
Low–Molecular-Weight-Heparins as Periprocedural Anticoagulation for Patients on Long-Term Warfarin Therapy: A Standardized Bridging Therapy Protocol
2005
Effect of Study Setting on Anticoagulation Control
2006
Quantification of right ventricular function in acute pulmonary embolism: relation to extent of pulmonary perfusion defects
2008
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Predictive Value of Factor V Leiden and Prothrombin G20210A in Adults With Venous Thromboembolism and in Family Members of Those With a Mutation
2009
Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting
2004
Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism
2006
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
2011
Initiation of warfarin therapy in elderly medical inpatients: A safe and accurate regimen
2005
Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study
2009
Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis
2014
Multidetector-Row Computed Tomography in Suspected Pulmonary Embolism
2005
The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment
2015
Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial
2011
Home Therapy of Venous Thrombosis with Long-term LMWH versus Usual Care: Patient Satisfaction and Post-thrombotic Syndrome
2009
Idarucizumab for Dabigatran Reversal
2015 Standout
Prevention of Venous Thromboembolism
2008 Standout
The Effect of Epsilon-Aminocaproic Acid and Aprotinin on Fibrinolysis and Blood Loss in Patients Undergoing Primary, Isolated Coronary Artery Bypass Surgery: A Randomized, Double-Blind, Placebo-Controlled, Noninferiority Trial
2009
Development of a Research Agenda for Inferior Vena Cava Filters: Proceedings from a Multidisciplinary Research Consensus Panel
2009
Calculating the sample size required for developing a clinical prediction model
2020 Standout
Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility
2010
The Prevalence of Symptomatic and Coincidental Pulmonary Embolism on Computed Tomography
2008
Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran
2003
Validation of a clinical algorithm to identify low‐risk patients with pulmonary embolism
2010
Relationship Between Deep Venous Thrombosis and the Postthrombotic Syndrome
2004
Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study
2011
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
2012
Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE
2016
Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer
2006
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease
2005
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Patients requiring interruption of long‐term oral anticoagulant therapy: the use of fixed sub‐therapeutic doses of low‐molecular‐weight heparin
2009
Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis
2015
Enlarged Right Ventricle Without Shock in Acute Pulmonary Embolism: Prognosis
2008
Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy
2010
Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients
2009
Deep-Vein Thrombosis of the Upper Extremities
2011
Deep vein thrombosis
2005
Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. a retrospective study of 2300 consecutive patients with venous thromboembolism
2005
A Randomized Clinical Trial Investigating the Relationship Between Aprotinin and Hypercoagulabilityin Off-Pump Coronary Surgery
2009
A New Risk Scheme to Predict Warfarin-Associated Hemorrhage
2011
Prospective validation of the Pulmonary Embolism Severity Index
2008
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
2017 Standout
D‐dimer, factor VIII coagulant activity, low‐intensity warfarin and the risk of recurrent venous thromboembolism
2006
Haemodynamically unstable pulmonary embolism in the RIETE Registry: systolic blood pressure or shock index?
2007
Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review
2009
Guidelines for the management of adult lower respiratory tract infections
2005
Management of Acute Proximal Deep Vein Thrombosis
2002
Development of a Contemporary Bleeding Risk Model for Elderly Warfarin Recipients
2006
Tranexamic Acid Reduces Blood Loss in Off-Pump Coronary Artery Bypass Surgery
2008
Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)
2006
Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal
2004
Postoperative Low‐Molecular‐Weight Heparin Bridging Is Associated with an Increase in Wound Hematoma Following Surgery for Pacemakers and Implantable Defibrillators
2009
Clinical performance of bleeding risk scores for predicting major and clinically relevant non‐major bleeding events in patients receiving warfarin
2013
Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study
2003
Troponin I and right ventricular dysfunction for risk assessment in patients with nonmassive pulmonary embolism in the Emergency Department in combination with clinically based risk score
2008
Prospective multicenter assessment of interobserver agreement for radiologist interpretation of multidetector computerized tomographic angiography for pulmonary embolism
2009
Hemorrhagic Complications of Anticoagulant Treatment
2004
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
A Randomized Trial of Genotype-Guided Dosing of Warfarin
2013
Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism
2012
Risk of stroke after surgery in patients with and without chronic atrial fibrillation
2010
Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism
2012
Quantitative Measures of Right Ventricular Dysfunction by Echocardiography in the Diagnosis of Acute Nonmassive Pulmonary Embolism
2006
Upper-extremity Deep Venous Thrombosis: A Review
2011
Deep venous thrombosis: a new task for primary health care A randomised economic study of outpatient and inpatient treatment
2004
External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges
2016
Derivation and Validation of a Prognostic Model for Pulmonary Embolism
2005
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism
2010
Escala de riesgo de eventos adversos a corto plazo en pacientes con tromboembolia pulmonar
2007
Diagnosis and Management of Isolated Subsegmental Pulmonary Embolism: Review and Assessment of the Options
2011
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Effectiveness of Managing Suspected Pulmonary Embolism Using an Algorithm Combining Clinical Probability, D-Dimer Testing, and Computed Tomography
2006
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum
2008
Ultrasonography and Diagnosis of Venous Thromboembolism
2004
Safely Ruling Out Deep Venous Thrombosis in Primary Care
2009
Comparative Outcomes of Catheter-Directed Thrombolysis Plus Anticoagulation vs Anticoagulation Alone to Treat Lower-Extremity Proximal Deep Vein Thrombosis
2014
“Bridging On the River Kwai”: The Perioperative Management of Anticoagulation Therapy
2005
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
A Randomized Trial of Diagnostic Strategies after Normal Proximal Vein Ultrasonography for Suspected Deep Venous Thrombosis: d -Dimer Testing Compared with Repeated Ultrasonography
2005
Validation of a model to predict adverse outcomes in patients with pulmonary embolism
2005
Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation
2016
Prevention of perioperative thromboembolism in patients with atrial fibrillation
2007
Outpatient Use of Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis of the Upper Extremity
1999
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer
2014
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Periprocedural Anticoagulation Management of Patients With Nonvalvular Atrial Fibrillation
2008
The Postthrombotic Syndrome: Evidence-Based Prevention, Diagnosis, and Treatment Strategies
2014
Platelet Function Measurement–Based Strategy to Reduce Bleeding and Waiting Time in Clopidogrel-Treated Patients Undergoing Coronary Artery Bypass Graft Surgery
2012
Duration of anticoagulation following venous thromboembolism: a meta-analysis.
2005
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
2014
Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy
2006
Guidelines for the Primary Prevention of Stroke
2014 Standout
Prediction of Pulmonary Embolism in the Emergency Department: The Revised Geneva Score
2006
Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis
2008
D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study
2014
The Wells Rule Does Not Adequately Rule Out Deep Venous Thrombosis in Primary Care Patients
2005
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Meta-Analysis: Outcomes in Patients with Suspected Pulmonary Embolism Managed with Computed Tomographic Pulmonary Angiography
2004
Cytokine Storm
2020 Standout
The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis
2014
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Epidemiology of cancer-associated venous thrombosis
2013
Warfarin plus Aspirin after Myocardial Infarction or the Acute Coronary Syndrome: Meta-Analysis with Estimates of Risk and Benefit
2005
N-Terminal Pro–Brain Natriuretic Peptide or Troponin Testing Followed by Echocardiography for Risk Stratification of Acute Pulmonary Embolism
2005
Periprocedural bridging therapy with low-molecular-weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: experience in 116 patients from the prospective BRAVE registry.
2007
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.
2003
Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis
2009
Systematic Review: d -Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism
2008
Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism
2008
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Perioperative Management of Patients on Oral Anticoagulants: A Decision Analysis
2005
The risk of bleeding with warfarin: A systematic review and performance analysis of clinical prediction rules
2007
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Evolving use of new oral anticoagulants for treatment of venous thromboembolism
2014
Computed tomographic pulmonary angiography in the assessment of severity of acute pulmonary embolism and right ventricular dysfunction
2009
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study
2008
Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability of d -Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism
2010
Below-Knee Elastic Compression Stockings To Prevent the Post-Thrombotic Syndrome
2004
Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin
2007
Evaluation of the Quality of Prognosis Studies in Systematic Reviews
2006
A Case of Massive Pulmonary Embolism With ST Elevation in Leads V1-4
2009
Role of Adenosine 3′,5′-Monophosphate in the Effects of Insulin and Anti-insulin Serum on Liver Metabolism
1968 StandoutNobel
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2013
Translating Clinical Research into Clinical Practice: Impact of Using Prediction Rules To Make Decisions
2006
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
The diagnostic odds ratio: a single indicator of test performance
2003 Standout
STUDIES ON EXPERIMENTAL DIABETES. 3. EFFECTS OF ACUTE INSULIN INSUFFICIENCY ON 14C-GLUCOSE FORMATION FROM LABELED SUBSTRATES.
1964
Withholding Anticoagulation after a Negative Result on Duplex Ultrasonography for Suspected Symptomatic Deep Venous Thrombosis
2004
Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism
2013
The Measurement of Observer Agreement for Categorical Data
1977 Standout
Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism
2010
Aggregating published prediction models with individual participant data: a comparison of different approaches
2012
How I treat isolated distal deep vein thrombosis (IDDVT)
2014
Works of Marc Rodger being referenced
Major bleeding during secondary prevention of venous thromboembolism in patients who have completed anticoagulation: a systematic review and meta‐analysis
2014
Cognitive and Behavioural Effects of Genetic Testing for Thrombophilia
2008
Unprovoked Venous Thromboembolism: Short term or Indefinite Anticoagulation? Balancing Long-Term Risk and Benefit
2010
Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta‐analysis
2011
A pilot study of central venous catheter survival in cancer patients using low‐molecular‐weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study)
2007
The effect of low‐molecular‐weight heparin on cancer survival. A systematic review and meta‐analysis of randomized trials
2007
Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis
2003 Standout
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode
2010
Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients
2009
Validation of a diagnostic approach to exclude recurrent venous thromboembolism
2009
Safety of outpatient treatment in acute pulmonary embolism
2010
Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10
2010
Does the Pulmonary Embolism Severity Index accurately identify low risk patients eligible for outpatient treatment?
2011
Thrombophilia and the Risk for Hemodialysis Vascular Access Thrombosis
2005
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
2008
Effectiveness of compression stockings to prevent the post-thrombotic syndrome (The SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial
2007
Computed Tomographic Pulmonary Angiography vs Ventilation-Perfusion Lung Scanning in Patients With Suspected Pulmonary Embolism
2007
Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trial
2010
A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction
2005
Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency
2012
Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
2013
Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis
2005
Pulmonary embolism
2018
D-dimer testing in pregnant patients: towards determining the next ‘level’ in the diagnosis of deep vein thrombosis
2010
A Randomized Trial Comparing 2 Low-Molecular-Weight Heparins for the Outpatient Treatment of Deep Vein Thrombosis and Pulmonary Embolism
2005
Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials
2016
Dead Space Ventilation Parallels Changes in Scintigraphic Vascular Obstruction at Recurrence of Pulmonary Embolism and after Thrombolytic Therapy: A Case Report
1998
Diagnostic value of the electrocardiogram in suspected pulmonary embolism
2000
Excluding pulmonary embolism at the bedside with low pre-test probability and D-dimer: Safety and clinical utility of 4 methods to assign pre-test probability
2005
The Outpatient Bleeding Risk Index
2003
Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta‐analysis of the management outcome studies
2010
The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy
2003
Diagnosis of pulmonary embolism: when is imaging needed?
2003
Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial
2008
Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism
2003
Outpatient treatment of symptomatic pulmonary embolism: A systematic review and meta-analysis
2013
Long‐term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial
2007
Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism
2010
Diagnosis of Pulmonary Embolism
2001
Inherited Thrombophilia and Pregnancy Complications Revisited
2008
Use of elastic compression stockings after deep venous thrombosis: a comparison of practices and perceptions of thrombosis physicians and patients
2003
Anticoagulants to prevent placenta-mediated pregnancy complications: a review of current evidence
2009
A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery
2008
The Association of Factor V Leiden and Prothrombin Gene Mutation and Placenta-Mediated Pregnancy Complications: A Systematic Review and Meta-analysis of Prospective Cohort Studies
2010
Risk of post‐thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study
2012
Systematic Review: The Trousseau Syndrome Revisited: Should We Screen Extensively for Cancer in Patients with Venous Thromboembolism?
2008
Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis.
1998
Extended Follow-up of the Multi-Center Multi-National Prospective Cohort Study That Derived the “Men Continue and HERDOO2” Clinical Decision Rule Which Identifies Low Risk Patients Who May Be Able to Discontinue Oral Anticoagulants (Oac) 5-7 Months After Treatment for Unprovoked Venous Thromboembolism (VTE).
2009
Comparison of 10-mg and 5-mg Warfarin Initiation Nomograms Together with Low-Molecular-Weight Heparin for Outpatient Treatment of Acute Venous Thromboembolism
2003
Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism
2004
VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism
2009
Treatment of Venous Thromboembolism
2014
Subsegmental Pulmonary Embolism Diagnosed by Computed Tomography: Incidence and Clinical Implications. A Systematic Review and Meta-Analysis of the Management Outcome Studies.
2009
Lessons From Ximelagatran: Issues for Future Studies Evaluating New Oral Direct Thrombin Inhibitors for Venous Thromboembolism Prophylaxis in Orthopedic Surgery
2008
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial
2008
Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin
2004
Evaluation of D-Dimer in the diagnosis of suspected deep-vein thrombosis
2004
A Pilot Study to Assess the Feasibility of a Multicenter Cluster Randomized Trial for the Management of Asymptomatic Persons with a Thrombophilia
2009
Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer
2000 Standout
Predicting Deep Venous Thrombosis in Pregnancy: Out in “LEFt” Field?
2009
Excluding Pulmonary Embolism at the Bedside without Diagnostic Imaging: Management of Patients with Suspected Pulmonary Embolism Presenting to the Emergency Department by Using a Simple Clinical Model and d -dimer
2001 Standout
Identifying Unprovoked Thromboembolism Patients at Low Risk for Recurrence Who Can Discontinue Anticoagulant Therapy
2009
Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism
2012
Clinical and Safety Outcomes Associated With Treatment of Acute Venous Thromboembolism
2014
Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin
2009
Inherited Thrombophilia and Pregnancy Complications Revisited
2009
A Red Blood Cell Agglutination d -Dimer Test to Exclude Deep Venous Thrombosis in Pregnancy
2007